ZYDUS WELLNESS Latest Share Price (ZYDUSWELL)
TODAY IN ONE LINE
ZYDUSWELL fell 2.5% on light volume, lagging Nifty's -0.3% move, supported by recent strong earnings.
With a market cap of ₹17,428.84 Cr., it trades at a P/E of 92.53. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
ZYDUS WELLNESS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 839.2% and Profit up 2061.8%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.04x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 5.8% YoY
- ●Poor Capital ReturnsLow ROE of 0.9%
- ●Expensive ValuationTrading at a high P/E ratio of 91.9x
- ●Promoter SellingPromoter holding decreased by 69.63% QoQ
Latest ZYDUS WELLNESS News
What changed recently?
Recent events, corporate actions, and announcements.
ZYDUS WELLNESS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for ZYDUS WELLNESS, framed against the sector median so the premium or discount is obvious at a glance.
ZYDUS WELLNESS trades at a P/E of 92.53× and P/B of 2.99×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
ZYDUS WELLNESS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for ZYDUS WELLNESS — derived from the latest tape, not yesterday's close.
ZYDUS WELLNESS last traded at ₹552 with an intraday range of ₹545.3–₹570 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹552.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 615.63 | +63.63 | +11.53% |
| R3 | 590.93 | +38.93 | +7.05% |
| R2 | 580.47 | +28.47 | +5.16% |
| R1 | 566.23 | +14.23 | +2.58% |
| PIVOT | 555.77 | 3.77 | 0.68% |
| CURRENT | 552.00 | — | — |
| S1 | 541.53 | -10.47 | -1.90% |
| S2 | 531.07 | -20.93 | -3.79% |
| S3 | 516.83 | -35.17 | -6.37% |
| S4 | 492.13 | -59.87 | -10.85% |
ZYDUSWELL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹558.2–₹570
Trading Below opening range, showing Bearishness
ZYDUS WELLNESS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for ZYDUS WELLNESS — consolidated or standalone — with margins, YoY growth and key ratios inline.
ZYDUS WELLNESS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹17,428.84 Cr. and reported EPS of ₹3.74.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,709 | 3,961 ▲ 46.2% |
| Sales Growth YoY %Derived | 16.37% | 46.22% |
| Other Income | 14 | 6 ▼ 52.9% |
| Total Income | 2,723 | 3,967 ▲ 45.7% |
| 1,278 | 1,567 ▲ 22.6% | |
| Gross ProfitDerived | 1,431 | 2,394 ▲ 67.3% |
| Gross Margin %Derived | 52.82% | 60.44% |
| 1,051 | 1,884 ▲ 79.3% | |
| EBITDA (Operating Profit)Derived | 380 | 510 ▲ 34.2% |
| OPM %Derived | 14.02% | 12.87% |
| 46 | 204 ▲ 340.6% | |
| Profit Before Tax (PBT) | 359 | 231 ▼ 35.8% |
| 12 | 33 ▲ 179.8% | |
| Effective Tax %Derived | 3.32% | 14.45% |
| Total Profit for Period | 347 | 197 ▼ 43.2% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 347 | 197 ▼ 43.2% |
| Net Profit Margin %Derived | 12.81% | 4.98% |
| PAT Growth YoY %Derived | 29.97% | -43.15% |
| Earnings Per Share (EPS ₹) | 10.90 | 6.20 ▼ 43.1% |
| Diluted Shares Outstanding (Cr) | 32 | 32 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | -1 | -5 ▼ 360.0% |
| Total Expenses (incl. D&A & Interest) | 2,364 | 3,737 ▲ 58.1% |
| Material Cost % of RevenueDerived | 43.73% | 30.61% |
| Employee Cost % of RevenueDerived | 8.76% | 7.90% |
| Other Cost % of RevenueDerived | 30.05% | 39.67% |
| Interest Coverage (x)Derived | 29.28x | 3.70x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 503 | 843 ▲ 67.5% | 1,767 ▲ 109.6% | 1,867 ▲ 5.7% | 2,009 ▲ 7.6% | 2,255 ▲ 12.2% | 2,328 ▲ 3.2% | 2,709 ▲ 16.4% | 3,961 ▲ 46.2% | |
| Sales Growth YoY %Derived | — | 67.51% | 109.63% | 5.65% | 7.63% | 12.23% | 3.24% | 16.37% | 46.22% | |
| Other Income | 35 | 39 ▲ 10.9% | 11 ▼ 72.5% | 9 ▼ 16.5% | 10 ▲ 16.3% | 5 ▼ 53.3% | 14 ▲ 186.0% | 14 ▼ 2.2% | 6 ▼ 52.9% | |
| Total Income | 538 | 882 ▲ 63.8% | 1,778 ▲ 101.6% | 1,876 ▲ 5.5% | 2,020 ▲ 7.7% | 2,260 ▲ 11.9% | 2,342 ▲ 3.6% | 2,723 ▲ 16.3% | 3,967 ▲ 45.7% | |
151 | 298 ▲ 97.0% | 779 ▲ 161.0% | 845 ▲ 8.5% | 980 ▲ 16.0% | 1,146 ▲ 16.9% | 1,138 ▼ 0.7% | 1,278 ▲ 12.3% | 1,567 ▲ 22.6% | ||
| Gross ProfitDerived | 352 | 544 ▲ 54.8% | 988 ▲ 81.5% | 1,022 ▲ 3.4% | 1,029 ▲ 0.7% | 1,109 ▲ 7.8% | 1,189 ▲ 7.3% | 1,431 ▲ 20.3% | 2,394 ▲ 67.3% | |
| Gross Margin %Derived | 69.90% | 64.60% | 55.92% | 54.74% | 51.20% | 49.18% | 51.10% | 52.82% | 60.44% | |
226 | 370 ▲ 63.4% | 667 ▲ 80.2% | 677 ▲ 1.6% | 684 ▲ 1.0% | 772 ▲ 12.8% | 881 ▲ 14.2% | 1,051 ▲ 19.3% | 1,884 ▲ 79.3% | ||
| EBITDA (Operating Profit)Derived | 125 | 174 ▲ 39.2% | 321 ▲ 84.1% | 344 ▲ 7.3% | 345 ▲ 0.1% | 337 ▼ 2.2% | 308 ▼ 8.6% | 380 ▲ 23.2% | 510 ▲ 34.2% | |
| OPM %Derived | 24.90% | 20.69% | 18.17% | 18.45% | 17.16% | 14.95% | 13.24% | 14.02% | 12.87% | |
11 | 43 ▲ 302.6% | 122 ▲ 186.6% | -23 ▼ 119.0% | 49 ▲ 312.0% | 31 ▼ 36.8% | 34 ▲ 8.2% | 46 ▲ 37.8% | 204 ▲ 340.6% | ||
| Profit Before Tax (PBT) | 150 | 171 ▲ 14.0% | 121 ▼ 28.9% | 112 ▼ 7.5% | 306 ▲ 172.7% | 291 ▼ 5.0% | 260 ▼ 10.6% | 359 ▲ 37.9% | 231 ▼ 35.8% | |
13 | -1 ▼ 104.6% | -20 ▼ 3252.5% | -7 ▲ 68.1% | -3 ▲ 56.3% | -20 ▼ 584.6% | -7 ▲ 65.1% | 12 ▲ 275.0% | 33 ▲ 179.8% | ||
| Effective Tax %Derived | 8.84% | -0.36% | -16.86% | -5.81% | -0.93% | -6.71% | -2.61% | 3.32% | 14.45% | |
| Total Profit for Period | 134 | 171 ▲ 27.9% | 142 ▼ 17.2% | 119 ▼ 16.2% | 309 ▲ 160.1% | 310 ▲ 0.5% | 267 ▼ 14.0% | 347 ▲ 30.0% | 197 ▼ 43.2% | |
| Less: Non-controlling Interests | — | 2 | — ▼ 100.0% | — | — | — | — | — | — | |
| Net Profit (Owner's PAT)Derived | 134 | 169 ▲ 26.3% | 142 ▼ 16.2% | 119 ▼ 16.2% | 309 ▲ 160.1% | 310 ▲ 0.5% | 267 ▼ 14.0% | 347 ▲ 30.0% | 197 ▼ 43.2% | |
| Net Profit Margin %Derived | 26.61% | 20.07% | 8.02% | 6.36% | 15.37% | 13.76% | 11.47% | 12.81% | 4.98% | |
| PAT Growth YoY %Derived | — | 26.32% | -16.21% | -16.22% | 160.14% | 0.49% | -14.01% | 29.97% | -43.15% | |
| Earnings Per Share (EPS ₹) | 6.85 | 5.87 ▼ 14.3% | 4.92 ▼ 16.2% | 3.73 ▼ 24.2% | 9.68 ▲ 159.5% | 9.76 ▲ 0.8% | 8.39 ▼ 14.0% | 10.90 ▲ 29.9% | 6.20 ▼ 43.1% | |
| Diluted Shares Outstanding (Cr) | 20 | 29 ▲ 47.6% | 29 ▲ 0.0% | 32 ▲ 10.3% | 32 ▲ 0.0% | 32 ▲ 0.0% | 32 ▲ 0.0% | 32 ▲ 0.0% | 32 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -3 | — ▲ 100.0% | — | — | — | — | — | — | — | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▼ 81.8% | 2 ▲ 10800.0% | 2 ▼ 16.1% | -1 ▼ 144.3% | 0 ▲ 108.6% | -0 ▼ 385.7% | -1 ▼ 400.0% | -5 ▼ 360.0% | |
| Total Expenses (incl. D&A & Interest) | 388 | 711 ▲ 83.0% | 1,656 ▲ 132.9% | 1,763 ▲ 6.5% | 1,713 ▼ 2.8% | 1,969 ▲ 14.9% | 2,082 ▲ 5.7% | 2,364 ▲ 13.6% | 3,737 ▲ 58.1% | |
| Material Cost % of RevenueDerived | 29.96% | 34.72% | 42.67% | 39.84% | 44.05% | 48.79% | 44.48% | 43.73% | 30.61% | |
| Employee Cost % of RevenueDerived | 11.26% | 10.16% | 9.89% | 8.78% | 8.14% | 7.42% | 8.31% | 8.76% | 7.90% | |
| Other Cost % of RevenueDerived | 33.75% | 33.76% | 27.86% | 27.52% | 25.90% | 26.80% | 29.55% | 30.05% | 39.67% | |
| Interest Coverage (x)Derived | 68.46x | 5.38x | 2.11x | 3.81x | 12.59x | 19.41x | 11.85x | 29.28x | 3.70x |
ZYDUS WELLNESS segment analysis : revenue and profit mix.
Disclosed business segments at ZYDUS WELLNESS with their share of revenue and profit, switchable between consolidated and standalone reporting.
ZYDUS WELLNESS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for ZYDUS WELLNESS.
Our AI distills the core fundamental drivers supporting ZYDUS WELLNESS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
ZYDUS WELLNESS's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 120 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.11%.
ZYDUS WELLNESS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — ZYDUS WELLNESS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
ZYDUS WELLNESS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for ZYDUS WELLNESS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
ZYDUS WELLNESS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for ZYDUS WELLNESS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in ZYDUS WELLNESS stood at 51.0% of traded volume, against a 20-day average of 42.8%.
ZYDUS WELLNESS announcements: results, concalls, ratings, M&A.
Filings ZYDUS WELLNESS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
ZYDUS WELLNESS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 179 documents below.
Spurt in Volume
Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant…
Spurt in Volume
Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant…
General Updates
Zydus Wellness Limited has informed the Exchange about ESG rating assigned by SES
Analysts/Institutional Investor Meet/Con. Call Updates
Zydus Wellness Limited has informed the Exchange about Schedule of meet
General Updates
Zydus Wellness Limited has informed the Exchange about Transcript of 32nd Annual General Meeting
Investor decks & rating reports.
ZYDUS WELLNESS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue ZYDUS WELLNESS has declared, sequenced by announce and record date.
ZYDUS WELLNESS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
ZYDUS WELLNESS insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in ZYDUS WELLNESS as reported to SEBI — buying and selling signals from the people who know the business best.
ZYDUS WELLNESS insider activity below tracks 30 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rajat Bhargava | Insider | 06 Mar 2026 | buy | +750 | ₹2.87 L | ₹383.14 |
| Rajat Bhargava | Insider | 06 Mar 2026 | buy | +750 | ₹2.87 L | ₹383.14 |
| Punit Adhia | Insider | 06 Mar 2026 | buy | +300 | ₹1.14 L | ₹381.00 |
| Yatin Desai | Insider | 04 Mar 2026 | buy | +500 | ₹1.9 L | ₹379.84 |
| Yatin Desai | Insider | 04 Mar 2026 | buy | +500 | ₹1.9 L | ₹379.84 |
| Vineet Shrivastava | Insider | 02 Mar 2026 | buy | +787 | ₹3.01 L | ₹382.03 |
About ZYDUS WELLNESS: business, sector, key facts.
What ZYDUS WELLNESS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
ZYDUS WELLNESS operates in the Packaged Foods industry under the Fast Moving Consumer Goods sector, listed as NSE: ZYDUSWELL, BSE: 531335.
Zydus Wellness Limited is a prominent Indian company specializing in the development, manufacturing, marketing, and distribution of a diverse portfolio of health and wellness products. Their operations span the entire value chain, from product conception to reaching consumers both domestically and internationally through exports. The company's extensive product line caters to a wide range of consumer needs and preferences, showcasing a commitment to offering choices within various health and wellness segments.
A significant portion of Zydus Wellness's business focuses on sugar substitutes. Under the Sugar Free brand umbrella (including variants like Sugar Free Gold, Natura, and Green), they offer a variety of products catering to individuals seeking healthier alternatives to traditional sugar. This segment highlights the company's responsiveness to evolving consumer health consciousness and the growing demand for sugar-free options.
Beyond sugar substitutes, Zydus Wellness boasts a strong presence in other key health and wellness categories. Complan, a milk-based health food drink, and Glucon-D, a glucose-based beverage, contribute substantially to their revenue streams, targeting consumers seeking nutritional supplements and energy boosts. Furthermore, their product portfolio includes I'm lite, a blended sugar coated with stevia, presenting another choice in the healthy sweetener market.
The company also holds a significant position in the personal care sector through established brands. Everyuth provides a range of skincare solutions including face washes, masks, and scrubs, while Nycil offers products addressing prickly heat, cooling needs, and hand hygiene. These diverse offerings demonstrate the company’s strategic diversification across related consumer product categories.
Finally, Zydus Wellness's Nutralite brand focuses on a selection of food products designed for health-conscious consumers. Their offerings include various spreads, such as probiotic butter, table spreads, ghee, and cholesterol-free alternatives, along with mayonnaise and chocolate spread. This segment indicates an expansion into the food sector with a health and wellness-oriented approach, aligning with their overall corporate strategy.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADF FOODS (ADFFOODS) Share PricePeer
- BOMBAY BURMAH TRADING COR (BBTC) Share PricePeer
- MRS BECTORS FOOD SPE (BECTORFOOD) Share PricePeer
- BIKAJI FOODS INTERN (BIKAJI) Share PricePeer
- BRITANNIA INDUSTRIES (BRITANNIA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about ZYDUS WELLNESS (ZYDUSWELL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of ZYDUS WELLNESS (ZYDUSWELL)?
The current share price of ZYDUS WELLNESS (ZYDUSWELL) is ₹552.00. Today, the stock has declined by ₹14.30 (2.53%), trading in a range of ₹545.30 to ₹570.00. The stock opened at ₹567.85 with a trading volume of 2,10,690 shares.
02Is ZYDUS WELLNESS stock a good investment for long-term?
ZYDUS WELLNESS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹17,428.84 Cr., P/E ratio of 92.53, ROE of 0.93%, and ROCE of 1.1%. The dividend yield stands at 0.22%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of ZYDUS WELLNESS stock?
The 52-week high price of ZYDUS WELLNESS (ZYDUSWELL) is ₹2,625.00, while the 52-week low is ₹367.55. Currently trading at ₹552.00, the stock is 50.18% above its 52-week low and 78.97% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy ZYDUS WELLNESS stock at the current price?
Whether to buy ZYDUS WELLNESS stock at ₹552.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 92.53 and P/B ratio of 2.99. Today's performance shows a loss of 2.53%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of ZYDUS WELLNESS and when is the next dividend?
ZYDUS WELLNESS offers a dividend yield of 0.22%, which means for every ₹100 invested at the current price of ₹552.00, you can expect to receive approximately ₹0.22 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of ZYDUS WELLNESS?
ZYDUS WELLNESS's key financial metrics include: P/E Ratio: 92.53, P/B Ratio: 2.99, ROE: 0.93%, ROCE: 1.1%, Dividend Yield: 0.22%, EPS: ₹3.74, Book Value: ₹183.11, and Debt-to-Equity: 0.04. The company's market cap stands at ₹17,428.84 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is ZYDUS WELLNESS stock performing today in the market?
ZYDUS WELLNESS stock opened at ₹567.85 and is currently trading at ₹552.00, showing a decline of ₹14.30 (2.53%). The intraday high is ₹570.00 and low is ₹545.30. The trading volume stands at 2,10,690 shares, indicating moderate market participation today.
08What is the P/E ratio of ZYDUS WELLNESS and what does it indicate?
ZYDUS WELLNESS has a Price-to-Earnings (P/E) ratio of 92.53, which means investors are willing to pay 92.53 for every ₹1 of earnings. With an EPS of ₹3.74, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about ZYDUS WELLNESS (ZYDUSWELL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.